tRNA containing ribothymidine at position 54
Protein C-terminal S-farnesyl-L-cysteine methyl ester
rRNA containing a single residue of 2'-O-methyladenosine
Colominic acid(non-reducing N- or O-acylneuraminyl residue)
Oligosaccharide with terminal 4-deoxy-6-methyl-alpha-D-galact-4-enuronosyl group
D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose
3-(Acyloxy)acyl group of bacterial toxin
Glycoprotein with the oligosaccharide chain attached by N-glycosyl linkage to protein L-asparagine
Nicotinic acid adenine dinucleotide phosphate
16alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with 2-furyl methyl ketone
Cocaine- and Amphetamine- regulated transcript (1-39)
Cocaine- and Amphetamine- regulated transcript (42-89)
Tuberoinfundibular peptide of 39 residues
(10S)-Juvenile hormone III diol phosphate
poly-cis-Polyprenyl diphosphate longer by one C5 unit
Hepta-acyl lipid A in lipopolysaccharide
(1->6)-alpha-D-Glucan containing a (1->3)-alpha-D-glucose branch
[Fe-S] cluster scaffold protein carrying a [4Fe-4S]2+ cluster
(1->6)-alpha-D-Glucan containing a (1->2)-alpha-D-glucose branch
Heparan sulfate containing L-iduronate 2-sulfate
3-O-Sulfated heparan sulfate containing L-iduronate 2-sulfate
Glycerol dibiphytanyl glycerol tetraether phospholipid
m7G(5')pppRm-RNA (mRNA containing a 2'-O-methylpurine cap)
S. suis serotype 1 capsular polysaccharide
S. suis serotype 1/2 capsular polysaccharide
S. suis serotype 1/2 desialylated polysaccharide
S. suis serotype 14 capsular polysaccharide
S. suis serotype 2 capsular polysaccharide
3,7-dichloroquinoline-8-carboxylic acid - dimethylamine (1:1)
desialylated S. suis serotype 1 capsular polysaccharide
desialylated S. suis serotype 14 capsular polysaccharide
desialylated S. suis serotype 2 capsular polysaccharide
EC 3.6.5.* (hydrolases acting on GTP; involved in cellular and subcellular movement) inhibitors
C18-[5]-ladderane fatty acid methyl ester
C20-[3]-ladderane fatty acid methyl ester
Glycopyrrolate mixture with formoterol fumarate
a polyunsaturated dicarboxylic fatty acid
a hydroperoxy polyunsaturated fatty acid
Proteus mirabilis O11 O-specific polysaccharide
Proteus mirabilis 9B-m O-specific polysaccharide
P. Penneri 37 and 44 LPS core oligosaccharide
2- (3,4,5-Trihydroxyphenyl) -3- [ 3-O- (3,4,5-trihydroxybenzoyl) -alpha-L-rhamnopyranosyloxy ] -5,7-dihydroxy-4H-1-benzopyran-4-one
a long-chain (3S)-3-hydroxy fatty acyl-CoA
a 3-(acyloxy)acyl derivative of bacterial toxin
a 3-hydroxyacyl group of bacterial toxin
O-(S-[C2-C8-saturated long-chain fatty acyl]pantetheine-4'-phosphoryl)-L-serine residue
an O-(S-[(7S)-hydroxy-C2-C8-saturated long-chain fatty acyl]pantetheine-4'-phosphoryl)-L-serine residue
an O-[S-((7R,8R)-7,8-dihydroxy-C2-C8-saturated long-chain fatty acyl)pantetheine-4-phosphoryl]-L-serine residue
AAA+ ATPase motor cytoplasmic dynein inhibitor
ATPase motor cytoplasmic dynein inhibitors
a 4-H-anthocyanidin with a 3-hydroxy group
a short-chain (3R)-hydroxy fatty acyl-CoA
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitors
a 2'-deoxyribose 5'-monophosphate in DNA
an archaeal dolichyl alpha-D-glucosyl phosphate
an archaeal dolichyl beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate
S. pneumoniae ST7F capsular polysaccharide
S. pneumoniae serotype 1 capsular polysaccharide
3-hydroxyacyl derivative of bacterial toxin
S. Typhimurium (serogroup B) O-polysaccharide
S. Enteritidis (serogroup B) O-polysaccharide
C-terminal glycine 3beta-cholesterol ester residue
a GPI-anchor amidated L-asparagine residue
a GPI-anchor amidated L-aspartate residue
2-chloro-N-(4'-chloro-5-hydroxybiphenyl-2- yl)nicotinamide conjugated to glucuronic acid
a GPI-anchor amidated carboxyl end residue
a GPI-anchor amidated L-cysteine residue
a GPI-anchor amidated L-threonine residue
a GIPC-anchor amidated L-asparagine residue
a GIPC-anchor amidated L-aspartate residue
a GIPC-anchor amidated L-alanine residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-adenosine residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-guanosine residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-(2'-O-methyl-adenosine) residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-(2'-O-methyl-guanosine) residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-adenosine-ribonucleotide residue
a 5'-end (N(7)-methyl 5'-triphospho-guanosine)-guanosine-ribonucleotide residue
(T-4)-bis(dibutylcarbamodithioato-S,S')zinc,  mixture with (T-4)-bis(diethylcarbamodithioato-S,S')zinc and N,N'-diphenylguanidine
an N-(very-long-chain fatty acyl)-sphingoid base
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate; trihydroxy(oxo)vanadium
an inositol-1-phospho-N-(2-hydroxy-very-long-chain fatty acyl)-4R-hydroxysphingoid base
an N-(omega-hydroxy-ultra-long chain fatty acyl)-sphingoid base
an N-[omega-(9Z,12Z-octadecadienoyloxy)-O-ultra-long chain fatty acyl]-sphingoid base
a ring-opened abasic DNA residue cross-linked to an L cysteinyl residue
an L-amino acyl-L-seryl dipeptide residue
an L-amino acyl-L-threonyl dipeptide residue
an L-amino acyl-L-cysteinyl dipeptide residue
an alpha-D-mannosyl-6-(1D-myo-inositol phospho)-(1<->6)-1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base
an alpha-D-mannosyl-(1<->6)-1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base
an N-(2R-hydroxy-very-long-chain fatty acyl)-(R)-4-hydroxysphingoid base
an N-(1,2 saturated very-long-chain fatty acyl)-(R)-4-hydroxysphingoid base
a 1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base
an N-(2-hydroxy-very-long-chain fatty acyl)-(R)-4-hydroxysphingoid base
an alpha-D-mannosyl-(1<->6)-1D-myo-inositol-1-phospho-N-(2-hydroxy-very-long-chain fatty acyl)-(R)-4-hydroxysphingoid base
an alpha-D-mannosyl-6-(1D-myo-inositol phospho)-(1<->6)-1D-myo-inositol-1-phospho-N-(2-hydroxy-very-long-chain fatty acyl)-(R)-4-hydroxysphingoid base
H. pylori serotype O6 tridecasaccharide O-antigen
an ultra-long-chain mono-unsaturated fatty acyl-pantetheine-4'-phosphoryl-L-serine residue
a 3-oxo-ultra-long-chain mono-unsaturated fatty acyl-pantetheine-4'-phosphoryl-L-serine residue
an ultra-long-chain di-unsaturated fatty acyl-pantetheine-4'-phosphoryl-L-serine residue
a 3-oxo-ultra-long-chain di-unsaturated fatty acyl-pantetheine-4'-phosphoryl-L-serine residue
a 5'-end (N(2),N(2),N(7)-trimethyl 5'-triphosphoguanosine)-purine ribonucleoside residue
a 5'-end (N(2),N(2),N(7)-trimethyl 5'-triphosphoguanosine)-guanosine residue
a 5'-end (N(2),N(2),N(7)-trimethyl 5'-triphosphoguanosine)-adenosine residue
a 5'-end (5'-triphosphoguanosine)-(2'-O-methyl-purine ribonucleoside) residue
an alpha-D-glucuronosyl-(1<->6)-1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base
Pentadecanoic acid, 14-methyl-, methyl ester
an N-(omega-(9Z,12Z-octadecadienoyloxy)-ultra-long chain fatty acyl)-sphing-4-enine
an N-(omega-hydroxy-ultra-long chain fatty acyl)-sphing-4-enine
3'-end deoxyribonucleotide 2,3-dehydro-2,3-deoxyribose phosphate residue
uridine 5'-[3-(6-deoxy-D-xylo-hexopyranosyl-4-ulose ) dihydrogen diphosphate]
L-Serine, 2-((aminoiminomethyl)amino)ethyl hydrogen phosphate (ester)
a 5'-end (N(2),N(2),N(7)-trimethyl 5'-triphosphoguanosine)-(ribonucleoside) residue
primary fluorescent dioxobilin-type chlorophyll catabolite
C-terminal L-amino acid-(phosphatidylethanolamine)-amidated glycine residue
C-terminal L-amino acid-(phosphatidylserine)-amidated glycine residue
a 3'-end uridine-uridine 2',3'-cyclophosphate residue
a 3'-terminal ribonucleotide 3'-(5'-diphosphoguanosine) residue
Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester
glycerol dibiphytanyl glycerol tetraether glycerophospholipid
a glycerol dibiphytanyl glycerol tetraether phospholipid
(2R,3S,4S)-2-(2-acetamido-2-deoxy-alpha-D-glucopyranosyloxy)-3,4-dihydroxypentane-1,5-diyl (2R,3S,4S)-2,3,4,5-tetrahydroxypentyl (2S,3R,4R)-2,3,4,5-tetrahydroxypentyl bis[hydrogen (phosphate)]
(2R,3S,4S)-2-(2-acetamido-2-deoxy-beta-D-glucopyranosyloxy)-3,4-dihydroxypentane-1,5-diyl (2R,3S,4S)-2,3,4,5-tetrahydroxypentyl (2S,3R,4R)-2,3,4,5-tetrahydroxypentyl bis[hydrogen (phosphate)]
(2R,3s,4S)-3-(2-acetamido-2-deoxy-beta-D-glucopyranosyloxy)-2,4-dihydroxypentane-1,5-diyl (2R,3S,4S)-2,3,4,5-tetrahydroxypentyl (2S,3R,4R)-2,3,4,5-tetrahydroxypentyl bis[hydrogen (phosphate)]
3,6-dichloro-o-anisic acid - 2-aminoethanol (1:1)
guanosine 5'-[3-(D-mannopyranosyluronic acid) dihydrogen diphosphate]
uridine 5'-[3-(2-acetamido-2-deoxy-D-mannopyranosyluronic acid) dihydrogen diphosphate]
flavin adenine dinucleotide semiquinone radical
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-N'-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (salt)
Cyclohexanecarboxylic acid (6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinolin-9-ylmethyl ester; compound with (Z)-but-2-enedioic acid
Phosphoric acid, 2-chloro-1-(2,4-dichlorophenyl)vinyl dimethyl ester
Phosphorothioic acid, O-(4-((dimethylamino)sulfonyl)phenyl) O,O-dimethyl ester
(1R,2S;1S,2R)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium, succinate (2:1), mixture with (+-)-(1R*,2S*;1R*,2S*)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium, succinate (2:1)
1(R)-2(S)-3(S)-4(S)-3-(4-methoxy-phenyl)-acrylic acid 3-(1,5-dimethyl- hex-1-enyl)-4- formyl-2-methoxy-cyclohexyl ester
cytidine 5'-(trihydrogen diphosphate), mono(2-(trimethylammonio)ethyl) ester
(1,10 PHENANTHROLINE)-(TRI-CARBON MONOXIDE) RHENIUM (I)
4H-Pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, calcium salt (1:1)
ortho- and peri-fused tricyclic hydrocarbons
N-carbamoyl-L-2-amino acid (a 2-ureido carboxylate)
Alexa Fluor 430 carboxylic acid, succinimidyl ester
Benzeneboronic acid, cyclic ((p-tolyloxy)methyl)ethylene ester
Alexa Fluor 350 carboxylic acid, succinimidyl ester
Alexa Fluor 405 carboxylic acid, succinimidyl ester
Alexa Fluor 532 carboxylic acid, succinimidyl ester
Alexa Fluor 546 carboxylic acid, succinimidyl ester
Alexa Fluor 568 carboxylic acid, succinimidyl ester
6-((4,4-difluoro-1,3-dimethyl-5-(4-methoxyphenyl)-4- bora-3a,4a-diaza-s-indacene-2-propionyl)amino)hexanoic acid, succinimidyl ester
4-amino-benzoic acid 2-diethylammonio-ethyl ester monocation
Benzoxazolium, 2,2 -[1,3-propanediylbis[(dimethyliminio)-3,1-propanediyl- 1(4H)-pyridinyl-4-ylidenemethylidyne]]bis[3-methyl]- , tetraiodide
6'-Methoxycinchonan-9-ol sulfate dihydrate, (8alpha,9R)-,(2:1) (salt)
Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt
Alexa Fluor 610-X carboxylic acid, succinimidyl ester
uridine 5-{3-[2-(acetylamino)-2-deoxy-D-glucopyranosyluronic acid] dihydrogen diphosphate}
Vibrio Cholerae O1, serotype Ogawa trisaccharide
guanosine 5'-(dihydrogen phosphate) 3'-(trihydrogen diphosphate)
(+-)-2-Hydroxypropanoic acid - hydroxyacetic acid copolymer
tertiary butyloxycarbonyl hydrazide of 3-(p-azobenzenearsonate)-N-acetyl-L-tyrosylglycylglycine
straight-chain saturated fatty acid anions
branched-chain saturated fatty acid anions
Vibrio Cholerae O1, serotype Ogawa disaccharide
Vibrio Cholerae O1, serotype Ogawa pentasaccharide
S. flexneri serotype 5a O-PS repeating unit
S. flexneri serotype 2a O-PS repeating unit
S. flexneri serotype 2b O-PS repeating unit
P. mirabilis O23 O-deacetylated O-PS repeating unit
Mycobacterium leprae PGL-1 outer disaccharide
Core oligosaccharide N. meningitis L2 type
S. thymurium SH 4809 O-PS dodecasaccharide
A. haemolyticus strain 57 O-PS repeating unit
A. haemolyticus strain 61 O-PS repeating unit
P. aeruginosa immunotype 3 O-PS repeating unit
P. aeruginosa serotype O11 O-PS repeating unit
p-chloromercuribenzoate derivative of penicillenic acid
inositol phosphomannosylinositol phosphoceramide A (C24)
inositol phosphomannosylinositol phosphoceramide A (C26)
inositol phosphomannosylinositol phosphoceramide B' (C24)
inositol phosphomannosylinositol phosphoceramide B' (C26)
inositol phosphomannosylinositol phosphoceramide B (C24)
inositol phosphomannosylinositol phosphoceramide B (C26)
inositol phosphomannosylinositol phosphoceramide C (C24)
inositol phosphomannosylinositol phosphoceramide D (C24)
inositol phosphomannosylinositol phosphoceramide D (C26)
S. pneumoniae type V capsular polysaccharide
Desialylated S. pneumoniae type V capsular polysaccharide
S. pneumoniae type VII capsular polysaccharide
C-terminal L-cysteine methyl ester residue
uridine 5'-[3-(2-acetamido-3-amino-2,3-dideoxy-alpha-D-ribo-hex-3-ulosepyranuronic acid) dihydrogen diphosphate]
Streptococcus pneumoniae serotype 19A pneumococcal polysaccharide
Streptococcus pneumoniae serotype 19F pneumococcal polysaccharide
Shigella flexneri serotype X O-specific polysaccharide
Shigella flexneri serotype 5b O-specific polysaccharide
Shigella flexneri serotype 3a O-specific polysaccharide
M. catarrhalis serotype A lipoligosaccharide
M. catarrhalis serotype B lipoligosaccharide
M. catarrhalis serotype C lipoligosaccharide
2-hydroxy-1,2,3-propanetricarboxylic acid, ammonium salt (1:3)
O,O'-bis(2-aminopropyl) polypropylene glycol-block-polyethylene glycol-block-polypropylene glycol
Vibrio Cholerae O1, serotype Ogawa tetrasaccharide
lucifer yellow carbohydrazide dye dianion
21-O-{(2E,6S)-2-hydroxymethyl-6-methyl-6-O-{4-O-(2'E,6'S)-2',6'-dimethyl-6'-O-[2'-O-(2''E,6''S)-2''-hydroxymethyl-6''-methyl-6''-O-beta-D-quinovopyranosyl-2'',7''-octadienoyl-beta-D-quinovopyranosyl]-2',7'-octadienoyl-beta-D-quinovopyranosyl}-2,7-octadienoyl}-3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-fucopyranosyl-(1->6)-[beta-D-glucopyranosyl(1->2)]-beta-D-glucopyranosyl} acacic acid 28-O-beta-D-glucopyranosyl-(1->3)-[alpha-L-arabinofuranosyl-(1->4)]-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl ester
1H-5,6,8b-Triazaacenaphthylene-3-carboxylic acid, 7-heptyl-2,2a,6,7,8,8a-hexahydro-4-methyl-, 9-(4-((4-((aminoiminomethyl)amino)butoxy)carbonyl)-1,2,3,5,6,7-hexahydro-1-iminopyrrolo(1,2-c)pyrimidin-3-yl)nonyl ester, (7S)-
Picras-3-en-21-oic acid, 15-((3,4-dimethyl-1-oxo-2-pentenyl)oxy)-13,20-epoxy-1,11,12-trihydroxy-2,16-dioxo-,methyl ester, (1beta,11beta,12alpha,15beta(E))-
Picras-3-en-21-oic acid, 13,20-epoxy-3,11,12,15-tetrahydroxy-2,16-dioxo-, methyl ester,(11beta,12alpha,15beta)-
2-[8-(acetyloxy)undecyl]-4,6-dihydroxy-, 8-(3,5-dihydroxyphenyl)-1-propyloctyl benzoic acid ester
2-Butenoic acid, 2-methyl-, (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-13,14-dimethoxy-6,7-dimethylcycloocta(1,2-f:3,4-f')bis(1,3)benzodioxol-5-yl ester, (2Z)-
16,24-Cyclo-D(17a)-homo-21-nor-17a-oxachola-16,20(22),23-triene-23-carboxylic acid, 1,6-dihydroxy-4,4,8-trimethyl-,methyl ester, (1beta,5alpha,6beta)-
2-propenoic acid, 2-methyl-, (3aR,4S,6R,10S,11S,11aS)-6-(acetyloxy)dodecahydro-11-hydroxy-6,10-dimethyl-3-methylene-2,7-dioxocyclodeca[b]furan-4-yl ester
gap junctional intercellular communication inhibitors
2-butenoic acid, 2-methyl-, (5R,6S,7R,8R)-5,6,7,8-tetrahydro-8-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-5-yl ester, (2E)-
2-Butenoic acid, 2-methyl-, (5R,6S,7R,8R,13aS)-8-(acetyloxy)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethylbenzo(3,4)cycloocta(1,2-f)(1,3)benzodioxol-5-ylester, (2Z)-
ent-Kaur-16-en-20-oic acid, 6,7,7,14,15-pentahydroxy-, 20,7-lactone, (6beta,7alpha,14R,15beta)-
Crinan-3-ol, 1,2-didehydro-, (3beta,5alpha,13beta,19alpha)- Trifluoroacetic acid
Crinan-3-ol, 1,2-didehydro-7-methoxy-, (3alpha)- Trifluoroacetic acid
2-butenedioic acid (2Z)-, dimethyl ester
11S-jalapinolic acid 11-O-beta-D-glucopyranosyl-(1->4)-O-(3-O-tigloyl)-beta-D-glucopyranosyl-(1->3)-O-(2-O-2S-methylbutyryl)-alpha-L-rhamnopyranosyl-(1->2)-[O-beta-D-glucopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->2)-beta-D-quinovopyranoside, intramolecular 1,2''''-ester
(E)-{(8alpha,13E,14alpha)-14-[2-(3-Furyl)ethyl]-8-methylpodocarpan-13-ylidene}methyl hydrogen sulfate - 1,1-dimethylguanidine (1:1)
rel-alpha-L-lyxo-Hex-2-ulosepyranuronic acid, 3,4-anhydro-3-C-[(2E,4E,6E)-1-hydroxy-3,7,11-trimethyl-2,4,6,10-dodecatetraen-1-yl]-, methyl ester
(S)-jalapinolic acid 11-O-(2-O-trans-cinnamoyl)-[(4-O-n-dodecanoyl)]-alpha-L-rhamnopyranosyl-(1->4)-O-(2-O-n-dodecanoyl)-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,2'' ester
(S)-jalapinolic acid 11-O-(2-O-trans-cinnamoyl)-[(4-O-n-dodecanoyl)]-alpha-L-rhamnopyranosyl-(1->4)-O-(2-O-n-decanoyl)-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3'' ester
Olean-12-en-28-oic acid, 3-(beta-D-glucopyranosyloxy)-2,16,23,24-tetrahydroxy-, O-D-apio-beta-D-furanosyl-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-6-deoxy-alpha-L-mannopyranosyl-(1->2)-L-arabinopyranosyl ester, (2beta,3beta,16alpha)-
Corynan-16-carboxylic acid, 19,20-didehydro-17-hydroxy-, methyl ester,(16R,19E)-
diammonium (2R)-3-[(12-aminododecanoyl)oxy]-2-(palmitoyloxy)propyl (2R)-2,3-bis(palmitoyloxy)propyl 2-hydroxypropane-1,3-diyl bis(phosphate)
oxidoreductase acting on NADH or NADPH inhibitor
non-peptide cyclic amidine C-N hydrolase inhibitor
S. pneumoniae type 23F capsular polysaccharide
beta-D-Glc-(1->4)-[alpha-D-GlcNAc-(1->2)-3-PEA-L-alpha-D-Hep-(1->3)]-L-alpha-D-Hep-(1->5)-Kdo [Click on the icon to display the ASCII name]
C20 fatty acyl-D-Phe-N-Me-L-Val-L-Ile-L-Phe-L-Ala methyl ester
Oligosaccharides with terminal 4-deoxy-6-methyl-alpha-D-galact-4-enuronosyl groups
7-azido-7-epi-Kdo alpha-allyl glycoside sodium salt
7-O-methyl-Kdo allyl glycoside sodium salt
Kdo-(2->8)-Kdo-1.7-lactone allyl glycoside sodium salt
4,7-diphenyl-1,10-phenanthroline 4',4''-disulfonic acid disodium salt
Le(b)-blood group A type 1 antigen hexaose
L-alpha-D-Hep-(1->7)-L-alpha-D-Hep-(1->3)-L-alpha-D-Hep-(1->5)-alpha-Kdo [Click on the icon to display the ASCII name]
16alpha,17-Dihydroxy-6alpha-methylpregn-4-ene-3,20-dione cyclic acetal with acetone
2-Oxo acid with one additional methylene group
Phosphorodithioic acid, S-((6-chloro-2-oxo-3(2H)-benzoxazolyl)methyl) O,O-diethyl ester
Biotin protein of malonate decarboxylase
a 3'-terminal ribonucleotide 3'-phosphate residue
a 3'-terminal ribonucleotide 2',3'-cyclic phosphate residue
a long-chain 2,3-saturated fatty acyl-CoA
a medium-chain 2,3-saturated fatty acyl-CoA
a very-long-chain 2,3-saturated fatty acyl-CoA
lipopolysaccharide, Escherichia coli 0111 B4
3'-terminal uridine 2',3'-cyclic phosphate residue
lipid A hexaacyl 1-(2-aminoethyl diphosphate)
lipid A 4'-(2-aminoethyl diphosphate) (E. coli)
a short-chain 2,3-saturated fatty acyl-CoA
an archaeal dolichyl N-acetyl-alpha-D-glucosaminyl phosphate
an archaeal dolichyl 3-O-(2,3-diacetamido-2,3-dideoxy- beta-D-glucuronsyl)-N-acetyl- alpha-D-glucosaminyl phosphate
C-terminal S-[(2E,6E)-farnesyl]-L-cysteine methyl ester residue
C-terminal L-leucine methyl ester residue
a very-long-chain 2,3,4-saturated fatty acyl CoA
an archaeal dolichyl 3-O-(2,3-diacetamido-2,3-dideoxy- beta-D-glucuronosyl)-N-acetyl- alpha-D-glucosaminyl phosphate